Domain
Pharmacy
NDC codes, dispensing, PBM, RxNorm and formulary management
1,921 pharmacy terms
The primary clinical indication or therapeutic reason documented to justify prescribing or compounding a specific drug formulation. Captured during medication reviews or prior authorization requests to establish medical necessity and ensure the formulation is appropriate for the patient's presenting condition.
Identifies a subordinate drug preparation type linked to a parent formulation record in a hierarchical pharmacy data model. Used in PBM and EHR drug master files to represent relationships between branded and generic variants, concentration levels, or delivery mechanisms, supporting formulary equivalence and drug substitution logic.
The municipality associated with the compounding pharmacy, dispensing facility, or manufacturer producing a specific drug formulation. Used in pharmacy licensing, regulatory compliance reporting, and supply chain management to identify geographic sourcing and ensure dispensing entities meet applicable state licensing requirements.
Designates the classification tier assigned to a drug preparation type within a structured pharmaceutical taxonomy, such as therapeutic class or chemical class. Used in PBM formulary systems, EHR clinical decision support, and drug utilization management to apply benefit rules, coverage policies, and step therapy protocols.
Stores the standardized alphanumeric identifier assigned to a specific drug preparation type within pharmacy, PBM, or EHR systems. Commonly aligned with NDC, RxNorm, or internal formulary coding schemes, this field drives claims adjudication, drug lookup, formulary tier assignment, and drug utilization review processes across healthcare data platforms.
The portion of a drug formulation's cost that a member is responsible for paying as a percentage of the allowed amount after any deductible is met, as defined by their pharmacy benefit plan. Captured during claims adjudication to calculate member out-of-pocket liability and determine the payer's reimbursement share.
Contains free-text notations entered by pharmacists, data stewards, or clinical staff regarding a specific drug preparation type in pharmacy or PBM systems. Used to document special handling instructions, compounding notes, formulary exceptions, or data quality flags that supplement structured fields in drug master and claims processing records.
The date on which compounding, preparation, or manufacturing of a specific drug formulation was finalized and deemed ready for dispensing or delivery. Used in pharmacy operations to track production timelines, calculate stability windows, assign expiration dates, and meet regulatory documentation requirements for compounded medications.
A flag designating that a drug formulation record contains sensitive information requiring restricted access, such as formulations associated with behavioral health, reproductive health, or substance use treatment. Controls data visibility within pharmacy and clinical systems to comply with applicable privacy regulations including 42 CFR Part 2.
Identifies the designated communication point, such as a person, department, or vendor, associated with a specific drug preparation type in pharmacy or PBM systems. Used to route inquiries about compounded drugs, manufacturer information, or formulary exceptions and supports procurement, regulatory, and clinical coordination workflows in healthcare data systems.
The fixed dollar amount a member is required to pay at the point of dispensing for a drug formulation, as specified by their pharmacy benefit plan tier structure. Captured during claims adjudication to determine patient cost-sharing obligations and calculate the net reimbursement due to the dispensing pharmacy.
Tracks the total number of occurrences or units associated with a specific drug preparation type within pharmacy, PBM, or EHR data systems. Used in drug utilization reporting, inventory management, claims analytics, and formulary audits to quantify dispensing frequency, prescription volume, and medication adherence across member populations.
The nation of origin or regulatory jurisdiction associated with a drug formulation's manufacturing source or dispensing location. Used in pharmacy supply chain management, import compliance tracking, and regulatory reporting to verify that formulations meet applicable FDA or international pharmaceutical standards and licensing requirements.
The unique identifier of the pharmacist, clinician, or system user who initially entered a drug formulation record into the pharmacy or clinical information system. Supports audit trail requirements, accountability tracking, and workflow management by establishing a clear record of who initiated the formulation entry.
Records the exact calendar date when a drug preparation type record was first created in a pharmacy, PBM, or EHR system. Used to establish audit trail integrity, support data lineage tracking, and enable time-based filtering in formulary management, drug master file maintenance, and regulatory compliance reporting workflows.
Timestamp recording when a drug formulation record was first entered into the pharmacy or clinical system. Used in audit trails and data lineage tracking to establish the origin point of compounded or manufactured drug preparation records within pharmacy management systems.
The kidney function marker for a drug preparation type. Used in healthcare data management and clinical workflows. This field is commonly used in electronic health records (EHR), healthcare information systems (HIS), and clinical data warehouses for formulation management and reporting.
Stores a general calendar date associated with a drug preparation type record in pharmacy or PBM systems. Depending on context, may represent a dispensing date, approval date, or review date. Used in drug lifecycle tracking, formulary audits, and claims processing to align medication records with relevant time periods in healthcare data pipelines.
Captures the combined date and timestamp for an event associated with a drug preparation type in pharmacy, PBM, or EHR systems. Provides precision beyond date-only fields for time-sensitive operations such as compounding timestamps, real-time claims adjudication, medication administration logging, and audit trail generation in healthcare data workflows.
The Drug Enforcement Administration registration number assigned to a specific drug formulation, particularly controlled substances. This identifier links the drug preparation to its DEA scheduling classification and is required for controlled substance dispensing, ordering, and regulatory compliance reporting in pharmacy systems.